Related Experiment Videos
Abdominal aortic aneurysm after pulmonary transplantation: a case report
1Division of Vascular Surgery, Department of Surgery, Vancouver Hospital, University of British Columbia, Vancouver, Canada.
Journal of Vascular Surgery
|March 10, 2000
Summary
This case study reports the first abdominal aortic aneurysm following lung transplantation. Immunosuppression therapy may contribute to aneurysm development and rapid growth in transplant recipients.
Area of Science:
- Cardiovascular Surgery
- Transplant Surgery
- Immunology
Background:
- A 39-year-old male with cystic fibrosis underwent bilateral lung transplantation 10 years prior.
- The patient was maintained on immunosuppressive therapy including cyclosporine, prednisone, and azathioprine.
- Abdominal aortic aneurysms (AAAs) are a significant vascular concern.
Observation:
- The patient presented with a symptomatic 5-cm abdominal aortic aneurysm.
- This represents the first documented case of an AAA in a lung transplant recipient.
- The aneurysm exhibited rapid enlargement, a characteristic also observed in heart transplant recipients.
Findings:
- The development of an AAA in a lung transplant recipient is a rare event.
- Rapid aneurysm growth was noted, similar to patterns seen in other solid organ transplant recipients.
- The patient's immunosuppression regimen was a key factor in his medical history.
Implications:
- Immunosuppressive therapy may play a role in the pathogenesis or accelerated growth of abdominal aortic aneurysms.
- This finding warrants further investigation into the link between immunosuppression and vascular complications after transplantation.
- Clinical vigilance for AAA development is crucial in long-term organ transplant survivors, particularly those on immunosuppressants.